Andrew N Schiff's Net Worth

$2.09 Million

Who is Andrew N Schiff?

Andrew N Schiff has an estimated net worth of $2.09 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, CEMPRA, INC., Aclaris Therapeutics, Inc., Monte Rosa Therapeutics, Inc., ViewRay, Inc., Zosano Pharma Corp, Esperion Therapeutics, Inc., ADMA BIOLOGICS, INC., Loxo Oncology, Inc., AGILE THERAPEUTICS INC, Elevation Oncology, Inc., Syros Pharmaceuticals, Inc., Cidara Therapeutics, Inc., T2 Biosystems, Inc., SafeStitch Medical, Inc., SUNESIS PHARMACEUTICALS INC, Durata Therapeutics, Inc., Versartis, Inc., MYOGEN INC, Sirion Holdings, Inc., Adams Respiratory Therapeutics, Inc., BARRIER THERAPEUTICS INC, INTERPHARM HOLDINGS INC, and PLANET TECHNOLOGIES, INC.

SEC CIK

Andrew N Schiff's CIK is 0001172252

Past Insider Trading and Trends

2014 was Andrew N Schiff's most active year for acquiring shares with 9 total transactions. Andrew N Schiff's most active month to acquire stocks was the month of May. 2015 was Andrew N Schiff's most active year for disposing of shares, totalling 6 transactions. Andrew N Schiff's most active month to dispose stocks was the month of November. 2021 saw Andrew N Schiff paying a total of $0.00 for 62,738 shares, this is the most they've acquired in one year. In 2014 Andrew N Schiff cashed out on 39,880 shares for a total of $792,970.75, their largest year based on trade value.